Compounds > 2-(1-(2-(1-methylpyrrolidino)ethyl)-1h-indol-3-yl)maleimide
Page last updated: 2024-10-23

2-(1-(2-(1-methylpyrrolidino)ethyl)-1h-indol-3-yl)maleimide and Anaphylaxis

2-(1-(2-(1-methylpyrrolidino)ethyl)-1h-indol-3-yl)maleimide has been researched along with Anaphylaxis in 1 studies

bisindolylmaleimide II: protein kinase C inhibitor; see also bisindolylmaleimide I

Anaphylaxis: An acute hypersensitivity reaction due to exposure to a previously encountered ANTIGEN. The reaction may include rapidly progressing URTICARIA, respiratory distress, vascular collapse, systemic SHOCK, and death.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
MacGlashan, D1

Other Studies

1 other study available for 2-(1-(2-(1-methylpyrrolidino)ethyl)-1h-indol-3-yl)maleimide and Anaphylaxis

ArticleYear
Expression of CD203c and CD63 in human basophils: relationship to differential regulation of piecemeal and anaphylactic degranulation processes.
    Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology, 2010, Volume: 40, Issue:9

    Topics: Anaphylaxis; Antigens, CD; Basophil Degranulation Test; Basophils; Biomarkers; Cell Degranulation; E

2010